Shivalik Rasayan gains on inking marketing agreement with China Chinopharma
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Shivalik Rasayan is currently trading at Rs. 853.00, up by 3.00 points or 0.35% from its previous closing of Rs. 850.00 on the BSE.
The scrip opened at Rs. 838.95 and has touched a high and low of Rs. 874.00 and Rs. 837.60 respectively. So far 214 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 1196.80 on 06-Jan-2022 and a 52 week low of Rs. 661.05 on 20-Jun-2022.
Last one week high and low of the scrip stood at Rs. 874.00 and Rs. 733.20 respectively. The current market cap of the company is Rs. 1235.93 crore.
The promoters holding in the company stood at 50.32%, while Institutions and Non-Institutions held 0.04% and 49.64% respectively.
Shivalik Rasayan (SRL) has entered into a long term marketing Agreement with China Chinopharma (CSC) to supply DMF grade Busalfan, API. The CSC shall hold Market Authorisation (MA) to sell SRL's Busalfan, API exclusively in China territory.
The CSC is a leader and pioneer who specialises in dealing with Pharmaceutical products having more than 20 years of experience.
Shivalik Rasayan is a manufacturer of organophosphorous based insecticides and chemicals.
